Susvimo 39,5 mg/0,395 ml, Injektionslösung in einer Durchstechflasche

7680705220014 CH-70522 S01LA04 11.99.0.

Active substances:

Ranibizumabum

No images available

Details

GTIN
7680705220014
Pharmacode
-
Product number
7052201
CPT
-
Packaging group
1
Unit
Durchstechflasche
Composition
ranibizumabum 100 mg, histidini hydrochloridum monohydricum et histidinum, saccharum, polysorbatum 20 100 µg, aqua ad iniectabile, ad solutionem pro 1 ml.

Articles (1)

Susvimo 39,5 mg/0,395 ml, Injektionslösung in einer Durchstechflasche
Injektionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
08/10/2026
Professional SmPC
Français
08/10/2026
Professional SmPC
Italien
08/10/2026

Detailed composition

Substance Quantity Type Category
ranibizumabum
100.0 MG Substance Wirkstoff (Principe actif)
histidini hydrochloridum monohydricum
- Substance HNIDK
histidinum
- Substance HNIDK
saccharum
- Substance HNIDK
polysorbatum 20
100.0 UG Substance HBESI
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Roche Pharma (Schweiz) AG

4058 Basel

Authorization information

Swissmedic authorization number
70522
Drug name
Susvimo, Injektionslösung in einer Durchstechflasche
Galenic form
LSINJ
ATC Code
S01LA04
Authorization status
Z
Dispensation category
B
First authorization
10/09/2026
Authorization expiration date
09/09/2031
IT number
11.99.0.
Domain
Human medicine
Field of application
Behandlung der neovaskulären (feuchten) altersabhängigen Makuladegeneration (AMD)

Packaging details

Description (FR)
SUSVIMO 39,5 mg/0,395 ml sol inj 100 mg 1 pce
Description (DE)
SUSVIMO 39,5 mg/0,395 ml Inj Lös 100 mg 1 Stk
Market launch
10/09/2026
Market withdrawal
10/09/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data